Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -10 of 10
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
5/22/2008
 
First Published:
5/4/2007
1.
Phase II Pilot Study of Irradiated Allogeneic Related Donor Lymphocyte Infusion in Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Biomarker/Laboratory analysis, Treatment
Active
Any age
NCI
CINJ-3330
NCT00161187
Last Modified:
8/5/2008
 
First Published:
5/1/2007
2.
Phase II Study of Combination Chemotherapy and Pegfilgrastim in Patients With Previously Untreated Germ Cell Tumors
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
18 and over
NCI
MSKCC-07044
07-044, NCT00470366
3.
Efficacy Study of Maintenance IT-101 Therapy for Ovarian Cancer Patients.
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
18 to 78
Pharmaceutical / Industry
OVAR0801
NCT00753740
4.
Phase I Study Using Sunitinib Plus Radiation Therapy for Cancer Patients
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Active
18 and over
Other
06C.549
NCT00437372
5.
Topotecan, Ifosfamide and Carboplatin in Children and Young Adults With Solid Tumors
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Active
45 and under
Other
2004-0079
NCT00502892
6.
Evaluation of Vasopressin in the Vessels of Ovarian Neoplasms
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Natural history/Epidemiology, Treatment
Active
18 and over
Other
TAMC 3H04
NCT00160472
Last Modified:
4/24/2008
 
First Published:
1/28/2007
7.
Study of a Non-Cross-Resistant Conditioning Regimen Followed By Single or Tandem Autologous Peripheral Blood Stem Cell Transplantation in Patients With Germ Cell Tumors
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Treatment
Active
10 to 69
NCI
UMN-2006LS032
UMN-MT2005-21, UMN-0608M90586, NCT00432094
8.
TRIAD Burden of Illness Mucositis Study
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Natural history/Epidemiology, Treatment
Active
18 and over
Other
No. 200509024
NCT00336609
9.
Respiratory Tumor and Normal Tissue Motion
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Natural history/Epidemiology, Treatment
Active
Not specified
Other
2003-0962
NCT00415675
10.
Thermal Spread Into the Interstitial Portion of the Fallopian Tubes Using the Ligasure Device at Time of Hysterectomy
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Health services research, Treatment
Active
21 and over
Other
08-092
NCT00746018
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute